explore -WSS

explore

author：hotspot 2025-10-02 00:17:59 - browse：14629

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

Biotech startup ReNAgade Therapeutics is cutting staff just seven months after raising the largest Series A round in the industry this year.

ReNAgade launched in May with hopes of becoming a one-stop shop for medicines targeting RNA, the genetic blueprints that cells use to make proteins instrumental in numerous diseases. These types of medicines are in high demand following the advent of mRNA vaccines for Covid and RNA-silencing therapies made by companies like Alnylam Pharmaceuticals.

ReNAgade was able to capitalize on that excitement when it raised a $300 million Series A round led by MPM Capital’s BioImpact Capital and F2 Ventures. But in recent days, the company decided to lay off around 10% of its 100-person team, according to a company statement and former employees’ posts on social media.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Florida health officials providing scant details on measles cases

WSS

STAT readers on older presidents, polypills, Medicare, and more

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Immune cells and nerve overgrowth may explain recurring UTI pain

Readout Newsletter: BridgeBio, Akero, and human embryo models

Ozempic has benefits for kidney disease as well as diabetes

hotspot

explore

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

A solution to the after

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

6 phony surgeries that take placebo to the extreme

ChatGPT in medicine: STAT answers readers' burning questions

Ed Silverman on new gene therapies, biosimilars, coffee, and more

In age of alternative facts, a scholarly course on calling out crap

Microsoft's Peter Lee: Generative AI could help doctors be more human

Wildfire smoke exposes gaps in outdoor worker protections

Pregnant women don't need prenatal multivitamins, study concludes

hotspot

In utero gene editing: an explainer

He's 19 months old and has one of the world’s rarest diseases

IVF doctors demand details after CooperSurgical lawsuit

A solution to the after

6 phony surgeries that take placebo to the extreme

Ed Silverman on new gene therapies, biosimilars, coffee, and more

leisure time

leisure time

explore

focus